Clinical Trial Update: Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial [NA]

View source ↗

Summary

A completed pilot feasibility randomized controlled trial (rePAIR) evaluating a novel approach to reduce inflammatory burden in end-stage renal disease, with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Periodontitis

Snippet

Sponsor: UConn Health | Conditions: Chronic Periodontitis, End Stage Renal Disease | NA | Status: COMPLETED